Fremont Richard D, Milstone Aaron P, Light Richard W, Ninan Mathew
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2650, USA.
J Heart Lung Transplant. 2007 Sep;26(9):953-5. doi: 10.1016/j.healun.2007.07.008.
Chylous effusions are a well-described complication of lymphangioleiomyomatosis (LAM) in both pre- and post-transplant patients. Chylous effusions can cause significant morbidity among patients and most treatment modalities have limitations to complete success. We describe the use of a pleurovenous shunt to treat a refractory chylous effusion in a patient after lung transplant for LAM. After shunt placement, the patient had complete resolution of the chylous effusion and subsequent discharge home after a prolonged hospitalization. The use of a pleurovenous shunt for refractory chylous effusions is a viable option after conventional therapy fails.
乳糜性胸腔积液是淋巴管平滑肌瘤病(LAM)在移植前和移植后患者中一种已被充分描述的并发症。乳糜性胸腔积液可导致患者出现严重的发病情况,并且大多数治疗方式在完全成功方面都存在局限性。我们描述了在一名因LAM接受肺移植术后的患者中使用胸膜静脉分流术治疗难治性乳糜性胸腔积液的情况。分流术后,该患者的乳糜性胸腔积液完全消退,在长期住院后随后出院回家。在传统治疗失败后,使用胸膜静脉分流术治疗难治性乳糜性胸腔积液是一种可行的选择。